Holding(s) in Company
March 11 2008 - 7:40AM
UK Regulatory
RNS Number:8280P
EiRx Therapeutics PLC
11 March 2008
Financial Services Authority
TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of Eirx Therapeutics Plc
existing shares to which voting rights are attached:
2. Reason for notification (please tick the appropriate box or boxes)
An acquisition or disposal of voting rights
An acquisition or disposal of financial instruments which may result in the acquisition
of shares already issued to which voting rights are attached
An event changing the breakdown of voting rights u
Other (please specify):
3. Full name of person(s) subject to the notification Barclays PLC
obligation:
4. Full name of shareholder(s) (if different from 3):
Barclays Stockbrokers Ltd
5. Date of transaction and date on which the threshold is 25-Feb-08
crossed or reached:
6. Date on which issuer notified: 06-Mar-08
7. Threshold(s) that is/are crossed or reached: 7% to 13%
8. Notified details:
A: Voting rights attached to shares
Class/type of Situation previous to Resulting situation after the triggering transaction
shares the Triggering
transaction
Number of Number of Number of Number of Voting Rights % of voting rights
If possible use Shares Voting Shares
ISIN code Rights
Direct Indirect Direct Indirect
GB00B0XQBS97 211,630,528 211,630,528 934,897,539 0 934,897,539 0.00 13.40
B: Financial Instruments
Resulting situation after the triggering transaction
Type of financial Expiration date Exercise/ conversion No. of voting rights Percentage of voting
instrument period/date that may be acquired rights
(if the instrument
exercised/converted)
N/A N/A N/A N/A N/A
Total (A+B)
Number of voting rights Percentage of voting rights
934,897,539 13.40
9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively
held, if applicable:
Barclays Stockbrokers Ltd
Proxy Voting:
10. Name of proxy holder: N/A
11. Number of voting rights proxy holder will cease N/A
to hold:
12. Date on which proxy holder will cease to hold N/A
voting rights:
13. Additional information: N/A
14. Contact name: Geoff Smith
15. Contact telephone number 020 7116 2913
For notes on how to complete form TR-1 please see the FSA website.
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLUAOARWKROAAR
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Eirx Therapeutics (LSE:ERX)
Historical Stock Chart
From Sep 2023 to Sep 2024